Repertoire Partners’s AdaptHealth AHCO Stock Holding History

Repertoire Partners’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000	Closed	-$19K	–	50
2022 Q3	$19K	Sell	1,000 -9,000	-90%	-$185K	0.01%	31
2022 Q2	$180K	Sell	10,000 -490,009	-98%	-$7.96M	0.06%	38
2022 Q1	$8.02M	Buy	500,009 +45,343	+10%	+$815K	0.52%	12
2021 Q4	$11.1M	Buy	+454,666	New	+$10.7M	9.19%	5

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Repertoire Partners's AHCO Position: Q4 2022 in Review

Repertoire Partners sold out of AdaptHealth (AHCO) in Q4 2022, closing a stake of 1,000 shares — an estimated $19K sold.

Repertoire Partners first reported a position in AHCO in Q4 2021 and held it in 4 quarters. The position peaked at $11.1M in Q4 2021. 193 funds tracked by Wall St. Rank hold AHCO as of Q4 2022.

Repertoire Partners reported no remaining AdaptHealth position as of Q4 2022 after selling out during the quarter.
Repertoire Partners sold 1,000 AdaptHealth shares in Q4 2022, an estimated $19K.
Repertoire Partners first reported a position in AdaptHealth in Q4 2021 and held it in 4 quarters.
Repertoire Partners's AdaptHealth position peaked at $11.1M in Q4 2021.
193 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2022.

Based on Repertoire Partners's 13F filing for Q4 2022, filed 14 Feb 2023.